Piper Sandler & Co’s Bausch Health BHC Stock Holding History

Piper Sandler & Co’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-1,976	Closed	-$201K	–	18
2015 Q4	$201K	Buy	+1,976	New	+$222K	0.51%	12

Other funds holding BHC

RCG

Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Piper Sandler & Co's BHC Position: Q1 2016 in Review

Piper Sandler & Co sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 1,976 shares — an estimated $201K sold.

Piper Sandler & Co first reported a position in BHC in Q4 2015 and held it in 1 quarter. The position peaked at $201K in Q4 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

Piper Sandler & Co reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
Piper Sandler & Co sold 1,976 Bausch Health shares in Q1 2016, an estimated $201K.
Piper Sandler & Co first reported a position in Bausch Health in Q4 2015 and held it in 1 quarter.
Piper Sandler & Co's Bausch Health position peaked at $201K in Q4 2015.
389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on Piper Sandler & Co's 13F filing for Q1 2016, filed 16 May 2016.